Pursuing claims-based data on what happens to patients taking their drugs, pharma companies have been striking pacts with payers and PBMs. Now, a heavyweight in the research field, IMS Health, has ...
The company's intangible assets--its proprietary data sets, technology, expertise, and reputation--place Quintiles IMS well ahead of its closest competitors. IMS Health's legacy business compiles ...
These harbingers reflect the deep and rapid changes in the global health sector that are upending business models and forcing all stakeholders to re-evaluate their approaches to bringing healthcare to ...
Health IT vendor IMS Health and biopharmaceutical research firm Quintiles Transnational Holdings have agreed to merge. Per the agreement, the companies will be combined in an all-stock merger of ...
IMS Health filed for an initial public offering last week, which may raise as much as $1 billion for the healthcare data and consulting firm. IMS Health was acquired in 2010 by private equity firms ...
VNU, owner of the market research firm A.C. Nielsen, is close to a deal to buy data provider IMS Health for $6.3 billion in cash and stock, the Wall Street Journal reported, citing sources it didn’t ...
CHICAGO (MarketWatch) -- IMS Health on Wednesday reported first-quarter net income of $118.1 million, or 56 cents a share, compared with last year's $30.3 million, or 13 cents a share. The figure in ...
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. Our 7,000 ...
NORWALK -- IMS Health, which provides market research to the pharmaceutical and health care industries, said Friday that it will cut 10 percent of jobs worldwide by the end of the year. IMS Health ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback